Cells use the NOTCH2 gene to pass along signals that guide development and help organs and bones form in an orderly way. This gene plays an important role in how tissues such as the skeleton, liver, kidneys, and heart mature and function. When a harmful variant disrupts this signaling, it can lead to genetic conditions including Hajdu-Cheney syndrome and some cases of Alagille syndrome.
What is a gene?
Genes are stretches of DNA that hold instructions your cells use to make molecules or regulate processes in the body. Some genes carry the information needed to produce proteins, the parts of cells that do much of the work. Others mainly direct when certain processes occur, where they occur, and how strongly they operate. Taken together, genes affect how the body develops and works, and they can also shape how you respond to food, stress, or medications. You can explore this topic further in the LearnHub.
Overview
NOTCH2Gene function
What if the gene works
The NOTCH2 gene helps cells send signals that guide growth, development, and specialization. It is especially important as tissues form and renew, including the skeleton and parts of the immune system.
Risk
What if the gene does not work
Variants in the NOTCH2 gene can disrupt development, most often causing Alagille syndrome with liver, heart, and facial features, or Hajdu-Cheney syndrome with bone loss and short stature. Milder and more severe variants can affect which features appear and when.
Treatment
What does that mean for your treatment
For pathogenic variants in the NOTCH2 gene, no NOTCH2-specific treatment or management approach is currently established; care is guided by the person’s clinical features rather than a NOTCH2-directed drug choice. The NOTCH2 gene and the wider Notch signaling pathway are being studied as drug targets and biomarkers in some cancers, but this has not led to routine gene-specific treatment for inherited NOTCH2 conditions.
Conditions associated with NOTCH2
Gene function
What if the gene works
Your cells constantly check in with nearby cells before they grow, specialize, or stay in place. The NOTCH2 gene helps run part of this contact based messaging system. Understanding how the NOTCH2 gene helps cells communicate makes it easier to see how tissues develop and renew in an orderly way.
The NOTCH2 gene helps neighboring cells pass signals by direct contact. Its protein sits on the cell surface and turns on when it meets matching signal proteins on another cell.
After activation, part of the NOTCH2 protein moves into the nucleus, the cell's control center. There it helps switch sets of genes on or off so cells follow the right instructions.
This pathway helps cells decide whether to keep dividing, begin specializing, or stay more flexible. It supports the timing of these choices so growth and renewal remain coordinated.
NOTCH2 signaling helps neighboring cells influence one another as tissues form and renew. This keeps cell behavior more organized across a tissue, rather than each cell acting on its own.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These differences are common and help shape normal human diversity, such as differences in appearance, metabolism, or how the body responds to environmental influences. Many have no noticeable effect and simply represent natural genetic variation. Sometimes, however, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the NOTCH2 gene can alter the receptor’s shape, shorten it, or change how long it stays active, showing how variants influence the NOTCH2 gene's function. Some reduce or stop signaling by lowering the amount of protein, while truncating changes near the gene’s end can remove a control region and keep signaling longer than usual. Milder variants may partly shift this pathway, while more disruptive variants can have larger effects and link to Alagille syndrome or Hajdu-Cheney syndrome.
How variants are linked to conditions
Pathogenic variants in the NOTCH2 gene can cause Hajdu-Cheney syndrome, a rare inherited condition linked to bone loss, short stature, and distinctive facial features. Variants in the same gene can also cause Alagille syndrome 2, which may affect the liver, heart, eyes, and skeleton. When people read about NOTCH2 gene variants linked to conditions, these are the main well-established diagnoses doctors mean.
A variant is not necessarily a diagnosis
Gene variants are a normal feature of human biology and are common throughout the general population. Most have no direct impact on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a confirmed diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For NOTCH2-related conditions, risk is usually driven mainly by whether a disease-causing variant is present, often because it runs in a family. There is not enough evidence to say that lifestyle changes lower the chance of developing a NOTCH2-related condition. For many living with a NOTCH2 change, regular follow-up and avoiding injury can help reduce complications, especially when bones are fragile.
Inheritance of NOTCH2 variants
For families asking about inheritance of the NOTCH2 gene variants, the best-established pattern is autosomal dominant. This means a change in one copy of the NOTCH2 gene can be enough to cause a NOTCH2-related condition. If a parent carries the variant, each child has a 50% chance of inheriting it. Some people with a NOTCH2-related condition have a new (de novo) variant that was not inherited from either parent.
What does my NOTCH2 result mean for my family?
A harmful change in the NOTCH2 gene is usually linked to conditions that can run in families in a dominant pattern, so close relatives such as parents, siblings, and children may also carry the same change. This can matter even if family members have milder features or have never been diagnosed. Some NOTCH2 changes happen for the first time in one person, so a parent is not always the source.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the NOTCH2 gene, doctors use genetic testing for NOTCH2 variants on DNA from a blood sample, saliva, or a cheek swab. The lab reads the gene and reports whether a variant was found, which can help clarify a diagnosis or family risk.
When should I consider getting a genetic test?
Consider testing for changes in the NOTCH2 gene if you or your child has features of Alagille syndrome, such as liver, heart, eye, or kidney findings, or signs of Hajdu-Cheney syndrome, including unusual bone loss, short stature, or repeated fractures. Testing can also make sense when these conditions run in the family.
A genetic result is only one part of your health story
A genetic finding can be informative, but what it can tell you varies with the condition and the specific kind of variant. Lifestyle, environment, age, and medical history all influence how the body functions over time. In some conditions, particularly those shaped by many genes, genetic information offers context instead of certainty and is best considered alongside other parts of care. In other situations, a genetic finding can give a clear answer. In areas like medication response, genetic results can help put personal experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the body, or responds to it at its target. Because of this, the same medicine may work better for some people, have less effect in others, or cause more side effects in some individuals.
What is Pharmacogenetics?
Pharmacogenetics examines the ways genetic differences shape how people respond to medications. By studying links between genes and drugs, it helps explain why the same treatment can affect one person differently than another. For many medicines, genes influence how the body handles a drug and how strong its effects may be. This information can support treatment choices that are better informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the NOTCH2 gene
When should I seek medical advice?
There isn't yet a broadly confirmed role for this gene in guiding medication choice or dose, so questions about side effects, new symptoms, or how well a treatment is working are best discussed with your doctor.
History
The NOTCH2 gene is part of the broader Notch signaling story, which began with fruit fly research in the early 1900s, when scientists noticed inherited changes affecting wing shape. Mammalian Notch genes, including the NOTCH2 gene, were identified later as researchers traced similar pathways in human development. Initially understood only through visible traits, later recognized as tied to a specific gene, NOTCH2 became important in explaining some inherited conditions that affect the liver, heart, bones, and facial features. In the 1990s and 2000s, studies linked variants in the NOTCH2 gene to some cases of Alagille syndrome. Later, researchers also connected specific changes in the NOTCH2 gene with Hajdu-Cheney syndrome. These discoveries helped turn a basic developmental pathway into a clinically useful part of human genetics.